1. Late outcome after surgical and topical treatment for Aspergillus mediastinitis after heart transplantation
- Author
-
Daniel Schmidlin, Paul Mohacsi, Carlos A. Mestres, Markus Flepp, Phillip Went, Pascal A. Berdat, Raed Aser, and Paul R. Vogt
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Topical treatment ,030204 cardiovascular system & hematology ,Aspergillus fumigatus ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Heart transplantation ,Voriconazole ,Aspergillus ,Debridement ,biology ,business.industry ,Chlorhexidine ,Mycotic aneurysm ,biology.organism_classification ,medicine.disease ,Mediastinitis ,Surgery ,030228 respiratory system ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
The 7-year long-term survival after Aspergillus fumigatus mediastinitis after heart transplantation, an uncommonly described condition, is herein reported. A 66-year-old male developed an infection with A. fumigatus covering the entire thoracic cavity with a fungal turf after orthotopic heart transplantation. Repeated surgical removal of infectious and necrotic tissue together with innovative topical treatment using voriconazole and chlorhexidine combined with systemic antifungal treatment, helped in controlling the infection. Definitive wound closure was achieved by standard sternal refixation and latissimus dorsi muscle flap plasty. Survival after A. fumigatus mediastinitis after heart transplantation was achieved with sequential debridement in combination with topical application of antifungal agents.
- Published
- 2021